ORACLE PARTNERS LP

CIK 00009419016 companiesGREENWICH, CT

SEC Profile

Transactions

Companies

Filings

CIK

0000941901

Recent Transactions

50 trades

Sale
Motus GI Holdings, Inc.
Common Stock
2021-01-26$1.90/sh−29,115→ 105,885 total
Sale
Motus GI Holdings, Inc.
Common Stock
2021-01-26$1.90/sh−30,000→ 0 total
Sale
BIOLASE, INC
Common Stock
2020-06-09$0.55/sh−1,196,590→ 1,276,500 total
Sale
BIOLASE, INC
Common Stock
2020-06-09$0.55/sh−79,841→ 184,300 total
Sale
BIOLASE, INC
Common Stock
2020-06-09$0.55/sh−47,885→ 0 total
Sale
BIOLASE, INC
Common Stock
2020-06-09$0.55/sh−10,400→ 0 total
Sale
BIOLASE, INC
Common Stock
2020-06-09$0.55/sh−435,596→ 278,300 total
Sale
BIOLASE, INC
Common Stock
2020-06-08$0.55/sh−358,744→ 264,141 total
Sale
BIOLASE, INC
Common Stock
2020-06-08$0.55/sh−564,738→ 713,896 total
Sale
BIOLASE, INC
Common Stock, par value $0.001 per share ("Common Stock")
2020-06-08$0.55/sh−2,479,456→ 2,473,090 total
Exercise of In-Money
Aspira Women's Health Inc.$AWHL
Common Stock
2020-06-08$1.80/sh+463,298→ 6,137,052 total
Sale
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2020-06-08$3.40/sh−150,918→ 655,000 total
Exercise of In-Money
Aspira Women's Health Inc.$AWHL
Warrants to acquire Common Stock
2020-06-08−463,298→ 0 total
Sale
SOLENO THERAPEUTICS INC$SLNO
Common Stock, par value $0.001 per share ("Common Stock")
2020-06-05$3.34/sh−49,325→ 805,918 total
Purchase
BIOLASE, INC
Series E Preferred Stock
2019-10-29$57.50/sh+2,783→ 2,783 total
Purchase
BIOLASE, INC
Series E Preferred Stock
2019-10-29$57.50/sh+1,843→ 1,843 total
Purchase
BIOLASE, INC
Series E Preferred Stock
2019-10-29$57.50/sh+12,765→ 12,765 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2019-07-26$2.14/sh+7,500→ 350,334 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock, par value $0.001 per share ("Common Stock")
2019-07-26$2.14/sh+49,569→ 2,665,050 total
Purchase
Motus GI Holdings, Inc.
Common Stock
2019-07-01$2.99/sh+5,000→ 30,000 total
Purchase
Motus GI Holdings, Inc.
Common Stock
2019-07-01$3.02/sh+35,000→ 135,000 total
Purchase
Motus GI Holdings, Inc.
Common Stock
2019-06-27$3.00/sh+138,698→ 550,698 total
Purchase
Motus GI Holdings, Inc.
Common Stock, par value $0.0001 per share ("Common Stock")
2019-06-27$3.00/sh+634,402→ 2,711,402 total
Purchase
Motus GI Holdings, Inc.
Common Stock
2019-06-27$3.00/sh+100,000→ 100,000 total
Purchase
Motus GI Holdings, Inc.
Common Stock
2019-06-27$3.00/sh+25,000→ 25,000 total
Purchase
Motus GI Holdings, Inc.
Common Stock
2019-06-27$3.00/sh+93,566→ 379,566 total
Sale
BIOLASE, INC
Common Stock
2019-06-25$1.50/sh−227,155→ 438,585 total
Sale
BIOLASE, INC
Common Stock
2019-06-25$1.50/sh−263,845→ 1,000,334 total
Sale
BIOLASE, INC
Common Stock, par value $0.001 per share ("Common Stock")
2019-06-25$1.50/sh−509,000→ 3,676,046 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2019-03-14$1.22/sh+20,360→ 855,243 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2019-03-14$1.20/sh+128→ 329,286 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock, par value $0.001 per share ("Common Stock")
2019-03-14$1.20/sh+900→ 2,520,246 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2019-03-14$1.22/sh+95,235→ 2,615,481 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2019-03-14$1.20/sh+192→ 834,883 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2019-03-14$1.22/sh+13,548→ 342,834 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock, par value $0.001 per share
2018-05-15$1.93/sh+256→ 551,423 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock, par value $0.001 per share
2018-05-15$1.93/sh+1,218→ 1,669,541 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock, par value $0.001 per share
2018-05-14$1.79/sh+8,426→ 551,167 total
Purchase
SOLENO THERAPEUTICS INC$SLNO
Common Stock, par value $0.001 per share
2018-05-14$1.79/sh+40,100→ 1,668,323 total
Purchase
BIOLASE, INC
Common Stock
2017-12-05$0.46/sh+10,745,615→ 30,866,265 total
Purchase
BIOLASE, INC
Common Stock
2017-12-04$0.30/sh+1,800,000→ 20,120,650 total
Exercise of In-Money
Aspira Women's Health Inc.$AWHL
Common Stock
2017-08-31$1.00/sh+583,333→ 9,825,289 total
Exercise of In-Money
Aspira Women's Health Inc.$AWHL
Warrants to acquire Common Stock
2017-08-31−583,333→ 0 total
Purchase
Aspira Women's Health Inc.$AWHL
Warrants to acquire Common Stock
2017-08-25+583,333→ 583,333 total
Expiration (Short)
Aspira Women's Health Inc.$AWHL
Warrants to acquire Common Stock
2017-08-25−583,333→ 0 total
Conversion
BIOLASE, INC
Common Stock
2017-06-30$1.24/sh+3,698,600→ 18,320,650 total
Purchase
BIOLASE, INC
Warrants to acquire Common Stock
2017-06-30$0.13/sh+1,800,535→ 3,144,811 total
Conversion
BIOLASE, INC
Series D Preferred Stock
2017-06-30−36,986→ 0 total
Purchase
Aspira Women's Health Inc.$AWHL
Common Stock, par value $0.001 per share
2017-02-17$1.40/sh+617,731→ 9,825,289 total
Purchase
Aspira Women's Health Inc.$AWHL
Warrant to acquire Common Stock
2017-02-17+1→ 0 total

Companies

Recent Filings

Address

C/O ORACLE INVESTMENT MANAGEMENT, INC. 200 GREENWICH AVENUE

GREENWICH, CT, 06830

View on SEC.gov